chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Gastrointestinal disorder, Headache, Injection site pain
Clinical narrative: muscle aches; fatigue; headache; shivering; fever; unspecified gastrointestinal symptoms; difficult to dress and do daily activities; can't move arm; injection site Grade 3 pain; pain; This case was reported by a consumer via call center representative and described the occurrence of pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st May 2022 18:16, the patient received the 2nd dose of Shingrix. On 31st May 2022, less than a day after receiving Shingrix, the patient experienced pain and injection site pain. On 1st June 2022, the patient experienced activities of daily living impaired. In June 2022, the patient experienced movement disorder. On an unknown date, the patient experienced myalgia, fatigue, headache, shivering, fever and gastrointestinal disorder. The patient was treated with ibuprofen and non-drug therapy (Heat Therapy). On an unknown date, the outcome of the pain, movement disorder, injection site pain, activities of daily living impaired, myalgia, fatigue, headache, shivering, fever and gastrointestinal disorder were not recovered/not resolved.   It was unknown if the reporter considered the pain, movement disorder, injection site pain, activities of daily living impaired, myalgia, fatigue, headache, shivering, fever and gastrointestinal disorder to be related to Shingrix.     Additional Information: GSK receipt date: 1-June-2022 Reporter's comment: This case was reported by a consumer via call center representative.  The patient received 2nd dose of Shingles shot at 6:16 pm. Around 9:30 pain got much worse. At 12:30am, the patient could hardly lift my arm.  The injection site Grade 3 pain continued. It was difficult to dress herself and do other daily activities this morning. On an unknown date, less than a week after vaccination, the patient experienced muscle aches, fatique, headache, shivering, fever and unspecified gastrointestinal symptoms.  The reporter consented to follow-up with physician but she had a new doctor she had not seen yet. No contact information provided. The patient might follow up with pharmacy where she received vaccination. She did not know the batch number or expiration date. The patient asked if it was normal. The Ibuprofen didn't help. Heat was not really either. Additional Supportive Information: note: Anatomical location of pain was not reported hence injection site pain and pain was coded as separate event.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Loss of personal independence in daily activities, Movement disorder, Myalgia, Pain, Pyrexia
Clinical narrative: muscle aches; fatigue; headache; shivering; fever; unspecified gastrointestinal symptoms; difficult to dress and do daily activities; can't move arm; injection site Grade 3 pain; pain; This case was reported by a consumer via call center representative and described the occurrence of pain in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st May 2022 18:16, the patient received the 2nd dose of Shingrix. On 31st May 2022, less than a day after receiving Shingrix, the patient experienced pain and injection site pain. On 1st June 2022, the patient experienced activities of daily living impaired. In June 2022, the patient experienced movement disorder. On an unknown date, the patient experienced myalgia, fatigue, headache, shivering, fever and gastrointestinal disorder. The patient was treated with ibuprofen and non-drug therapy (Heat Therapy). On an unknown date, the outcome of the pain, movement disorder, injection site pain, activities of daily living impaired, myalgia, fatigue, headache, shivering, fever and gastrointestinal disorder were not recovered/not resolved.   It was unknown if the reporter considered the pain, movement disorder, injection site pain, activities of daily living impaired, myalgia, fatigue, headache, shivering, fever and gastrointestinal disorder to be related to Shingrix.     Additional Information: GSK receipt date: 1-June-2022 Reporter's comment: This case was reported by a consumer via call center representative.  The patient received 2nd dose of Shingles shot at 6:16 pm. Around 9:30 pain got much worse. At 12:30am, the patient could hardly lift my arm.  The injection site Grade 3 pain continued. It was difficult to dress herself and do other daily activities this morning. On an unknown date, less than a week after vaccination, the patient experienced muscle aches, fatique, headache, shivering, fever and unspecified gastrointestinal symptoms.  The reporter consented to follow-up with physician but she had a new doctor she had not seen yet. No contact information provided. The patient might follow up with pharmacy where she received vaccination. She did not know the batch number or expiration date. The patient asked if it was normal. The Ibuprofen didn't help. Heat was not really either. Additional Supportive Information: note: Anatomical location of pain was not reported hence injection site pain and pain was coded as separate event.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Fear, Injury, Ophthalmic herpes zoster, Scar, Vaccination failure
Clinical narrative: suspected vaccination failure/came out with the two shot shingles shot, paid for it, shingles in eye; went through a trauma and got shingles in the eye/came out with the two shot shingles shot, paid for it, shingles in eye; scar tissue which makes my vision blurry; terrible trauma; scar; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (experienced shingles when the patient was in his/her 30's). Previously administered products included Shingles vaccine.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, unknown after receiving Shingles vaccine and an unknown time after starting Valtrex, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), blurred vision, injury and scar. The patient was treated with valaciclovir hydrochloride (Valtrex) and ophthalmologicals (nos) (Eyes Drops (Nos)). On an unknown date, the outcome of the vaccination failure and injury were unknown and the outcome of the ophthalmic herpes zoster was recovered/resolved and the outcome of the blurred vision and scar were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, blurred vision, injury and scar to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 1-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient came out with the two shot shingles shot. The patient's insurance did not cover it, so he/she paid for it. Two months later the patient went through a terrible trauma and got shingles in left eye. The patient was on three different drops for eyes and the Valtrex since 4th February 2022. The patient had scar tissue which made his/her vision blurry, so now the patient had to take the Valtrex for the rest of life. Out of fear the shingles will come back and he/she would lose total vision. The patient stated that you could get shingles many times . So don't sweat the little things and try not to sweat the big things either. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles was not provided
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Vision blurred
Clinical narrative: suspected vaccination failure/came out with the two shot shingles shot, paid for it, shingles in eye; went through a trauma and got shingles in the eye/came out with the two shot shingles shot, paid for it, shingles in eye; scar tissue which makes my vision blurry; terrible trauma; scar; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (experienced shingles when the patient was in his/her 30's). Previously administered products included Shingles vaccine.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, 2 months after receiving Shingles vaccine, unknown after receiving Shingles vaccine and an unknown time after starting Valtrex, the patient experienced vaccination failure (serious criteria GSK medically significant), ophthalmic herpes zoster (serious criteria GSK medically significant), blurred vision, injury and scar. The patient was treated with valaciclovir hydrochloride (Valtrex) and ophthalmologicals (nos) (Eyes Drops (Nos)). On an unknown date, the outcome of the vaccination failure and injury were unknown and the outcome of the ophthalmic herpes zoster was recovered/resolved and the outcome of the blurred vision and scar were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, blurred vision, injury and scar to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 1-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient came out with the two shot shingles shot. The patient's insurance did not cover it, so he/she paid for it. Two months later the patient went through a terrible trauma and got shingles in left eye. The patient was on three different drops for eyes and the Valtrex since 4th February 2022. The patient had scar tissue which made his/her vision blurry, so now the patient had to take the Valtrex for the rest of life. Out of fear the shingles will come back and he/she would lose total vision. The patient stated that you could get shingles many times . So don't sweat the little things and try not to sweat the big things either. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles was not provided
Sex: U
Vaccine: VARZOS
Symptoms: Illness, Insomnia, Malaise
Clinical narrative: I got very sick, it was terrible; didn´t sleep one minute last night; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date).   On 31st May 2022, the patient received the 2nd dose of Shingles vaccine. On 31st May 2022, less than a day after receiving Shingles vaccine, the patient experienced sickness and insomnia. On an unknown date, the outcome of the sickness and insomnia were unknown.   It was unknown if the reporter considered the sickness and insomnia to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 1-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received Shingles vaccine on the day before the date of reporting. After vaccination, the patient got very sick  and did not sleep one minute at the night before the date of reporting.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Burning sensation, Herpes zoster, Pain, Vaccination failure
Clinical narrative: had both shot, broke out with shingles/suspected vaccination failure; shingles, right side of face; extreme pain; feels like face is on fire; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In May 2022, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain and burning sensation. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, pain and burning sensation were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and burning sensation to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 1-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had both Shingles shot, but last week he/she broke out with shingles on the right side of face. The patient do believe if he/she had not had the shots it would be much worse than it is. It was extreme pain, very painful. At times it just feels like his/her face was on fire. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles was not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous
Clinical narrative: large red rash on both legs; This case was reported by a consumer via interactive digital media and described the occurrence of red rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced red rash. On an unknown date, the outcome of the red rash was unknown.   It was unknown if the reporter considered the red rash to be related to Shingrix.     Additional Information: GSK Receipt Date: 1-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received Shingrix and had large red rash on both legs. The patient asked if it was common after vaccination. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: shingles flare up; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 2-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient recently got the Shingrix vaccine and was having shingles flare up at the time of reporting. The patient had the anti-viral medicines and the patient was asking if he or she should take it or not.  Additional Supportive Information: Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Sensitive skin, Sunburn
Clinical narrative: Skin sensitivity along my back; Feels like I am sunburned; This case was reported by a consumer via interactive digital media and described the occurrence of sensitive skin in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th April 2022, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced sensitive skin and sunburn. On an unknown date, the outcome of the sensitive skin and sunburn were unknown.   It was unknown if the reporter considered the sensitive skin and sunburn to be related to Shingrix.     Additional Information: GSK Receipt Date: 1-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient had shingles vaccination. Since that time the patient developed a skin sensitivity along back. The patient felt like he or she was sunburned. The patient was wondering if that was a side effect from the vaccination or not. Additional Supportive Information: Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain
Clinical narrative: Three days after shingles shot, got shingles; painful, constant pain; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included pain.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 3 days after receiving Shingles vaccine, the patient experienced shingles and pain. On an unknown date, the outcome of the shingles was unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the shingles and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-JUN-2022 Reporter's comment: This case was reported by a patient via interactive digital media Three days after getting the shingles shot, the patient got shingles, so painful and the bad thing was that this was a constant pain still after about 6 years. Additional supportive information: Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: got my first shot on 2019, and get the second one now, is this ok; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (the patient got first shot of Shingrix in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 02-JUN-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient's doctor said that, go ahead and took second dose of Shingrix now. The reporter wanted to know if this was okay. The patient stated that, how often did you have Shingrix shots. Additional Supportive Information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The follow-up would not possible as no contact details were available.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: Inappropriate schedule of vaccine; Sore Arm; Tiredness; Headache; Chills; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix with an associated reaction of chills (1st dose received on 14th January 2021 and experienced chills, headache, tiredness and sore arm, refer linked case US2022088490).   On 2nd June 2022, the patient received the 2nd dose of Shingrix. On 2nd June 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. In June 2022, the patient experienced pain in arm, tiredness, headache and chills. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain in arm, tiredness, headache and chills were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain in arm, tiredness, headache and chills to be related to Shingrix.     Linked case(s) involving the same patient:  US2022088490   Additional Information: GSK Receipt Date: 03-Jun-2022 Reporter's Comments: The patient stated that with both doses she had experienced chills, headache, tiredness, and a sore arm.  Adverse events filed.  Gave medical disclaimer.  The reporter consented to follow up. Additional Supportive: The patient received her second dose later than the recommended standard interval, which led to lengthening of the vaccination schedule.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022088490:same report
Sex: U
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome, Mobility decreased, Pain
Clinical narrative: got Gillian Barre Syndrome; pain gets worse and its horrible; partial use of my leg now, The other leg is failing too; This case was reported by a consumer and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant), pain and mobility decreased. On an unknown date, the outcome of the guillain barre syndrome, pain and mobility decreased were unknown.   The reporter considered the guillain barre syndrome to be related to Shingrix. It was unknown if the reporter considered the pain and mobility decreased to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-JUN-2022  Reporter's Comments: The patient got Guillain Barre syndrome from the vaccination four months  ago from reporting date and the pain just got worse and was horrible.  The patient also had partial use of his/her leg now and the other leg was failing too.  The patient was finally getting to see a neurologist tomorrow.  The patient asked what else he/she could do before this gets even more destructive to his/her body.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Arm was sore a fee days; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The patient got the first dose of the shingle shot. The patient had sore arm for few days. Additional Supportive: The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Incomplete course of vaccination
Clinical narrative: I got my first dose of Shingrix 11 months ago; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date 11 months ago from reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 02-JUN-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient enquired that he/she received 1st dose of Shingrix 11 months ago, so was it too late to get second dose and asked what he/she could do. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. Follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: everyone I know that got the Shingrix had only an arm sore; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-Jun-2022 Reporter's Comments: The reporter reported the case via interactive digital media. The reporter reported that it's very strange that everyone he/she knew that got the Shingrix had only an arm sore. Additional Supportive  The follow-up would not possible, as no contact details were available. This case is linked to the case US2022AMR088928, reported by the same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR088928:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Got shingles after my 1st shot, horrible enough; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-JUN-2022 Reporter's Comments:  The patient self-reported this case via interactive digital media. The patient experienced Shingles after receiving 1st dose of Shingles vaccine. The patient said he/ she was so glad and could not imagine how horrible it could have been. The patient said it was horrible enough to go through already being vaccinated. The reporter advised people not to put themselves at risk get their shots. The follow-up would not possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Post herpetic neuralgia, Vaccination failure
Clinical narrative: had the vaccines but still got them several years ago/suspected vaccination failure; still got shingles several years ago; got shingles several years ago and still suffers from nerve pain; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and post herpetic neuralgia. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the post herpetic neuralgia was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and post herpetic neuralgia to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 03-JUN-2022 Reporter's comment: This case was reported via interactive digital media. The reporter's father had the vaccines but still got them several years prior to the reporting and still suffered from nerve pain. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome
Clinical narrative: guillian barre syndrome; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was not recovered/not resolved.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-JUN-2022 Reporter's Comment: This case was reported by the patient via interactive digital media. The patient got a Shingrix vaccination and now he/she have had Guillain barre syndrome for four months. Additional Supportive Information: The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: ache all over; This case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (a few years ago patient had a slight occurrence of shingles on one arm). Previously administered products included Shingles vaccine (got the old vaccine about 10 years ago).   On 1st June 2022, the patient received Shingles vaccine. In June 2022, less than a week after receiving Shingles vaccine, the patient experienced general body pain. On an unknown date, the outcome of the general body pain was unknown.   It was unknown if the reporter considered the general body pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-JUN-2022 Reporter's Comments: The patient self-reported this case via interactive digital media. The patient got the old vaccine about 10 years ago and a few years ago he/she had a slight occurrence of shingles on one arm. Doctor recommended getting the newer vaccine so on 1st June 2022 patient received Shingles vaccine, and he/she had ache all over.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Inappropriate schedule of product administration, Nausea, Pain, Pain in extremity
Clinical narrative: Sore arm; Headache; Body aches; nausea; Drug dose administration interval too short; Did not sleep well last night; This case was reported by a consumer via interactive digital media and described the occurrence of poor sleep in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 2nd June 2022, the patient received the 2nd dose of Shingrix. On 2nd June 2022, less than a day after receiving Shingrix, the patient experienced poor sleep and drug dose administration interval too short. On 3rd June 2022, the patient experienced pain in arm, headache, general body pain and nausea. On an unknown date, the outcome of the poor sleep and drug dose administration interval too short were unknown and the outcome of the pain in arm, headache, general body pain and nausea were recovering/resolving.   It was unknown if the reporter considered the poor sleep, pain in arm, headache, general body pain and nausea to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The reporter was patient's husband. The reporter stated that the first shot was 6 weeks ago. The husband reported that the patient received her 2nd dose of shingrix in the left arm.  The patient did not sleep well last night, and next morning the patient experienced sore arm, headache, body aches, and nausea.  The reporter stated that patient's symptoms were better. The patient asked if she could take Ibuprofen for side effects from her 2nd shingrix shot. Additional Supportive Information: The patient received 2nd dose 6 weeks after receiving 1st dose, earlier than the recommended standard schedule, which led to shortening of the vaccination schedule. The follow-up would not possible as no contact details were available.
Age: 79.0
Sex: F
Vaccine: VARZOS
Symptoms: Poor quality sleep
Clinical narrative: Sore arm; Headache; Body aches; nausea; Drug dose administration interval too short; Did not sleep well last night; This case was reported by a consumer via interactive digital media and described the occurrence of poor sleep in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included RECOMBINANT VARICELLA ZOSTER VIRUS SURFACE GLYCOPROTEIN E (SHINGRIX).   On 2nd June 2022, the patient received the 2nd dose of Shingrix. On 2nd June 2022, less than a day after receiving Shingrix, the patient experienced poor sleep and drug dose administration interval too short. On 3rd June 2022, the patient experienced pain in arm, headache, general body pain and nausea. On an unknown date, the outcome of the poor sleep and drug dose administration interval too short were unknown and the outcome of the pain in arm, headache, general body pain and nausea were recovering/resolving.   It was unknown if the reporter considered the poor sleep, pain in arm, headache, general body pain and nausea to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-Jun-2022 Reporter's Comments: The patient self-reported the case via interactive digital media. The reporter was patient's husband. The reporter stated that the first shot was 6 weeks ago. The husband reported that the patient received her 2nd dose of shingrix in the left arm.  The patient did not sleep well last night, and next morning the patient experienced sore arm, headache, body aches, and nausea.  The reporter stated that patient's symptoms were better. The patient asked if she could take Ibuprofen for side effects from her 2nd shingrix shot. Additional Supportive Information: The patient received 2nd dose 6 weeks after receiving 1st dose, earlier than the recommended standard schedule, which led to shortening of the vaccination schedule. The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia
Clinical narrative: woke up in the middle of the night with knee pain; This case was reported by a other health professional via interactive digital media and described the occurrence of knee pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th May 2022, the patient received Shingles vaccine. On 28th May 2022, 2 days after receiving Shingles vaccine, the patient experienced knee pain. On an unknown date, the outcome of the knee pain was not recovered/not resolved.   It was unknown if the reporter considered the knee pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 03-JUN-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient was a healthcare provider, received Shingles vaccine last Thursday, 1 week ago.  On Saturday am, the patient woke up in the middle of the night with right knee pain.  The patient did not ever had knee pain and it was still present a week after. Additional Supportive Information: Follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: received vaccine, still get shingles/Suspected vaccination failure; shingles; pain is still terrible; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK receipt date: 03-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient received the Shingles vaccine and still get shingles often. The symptoms did not last as long, but the pain was still terrible. Additional supportive information: This case was considered to be a suspected vaccination failure case, as the details regarding completion of primary vaccination schedule, laboratory confirmation for shingles and time to onset were unknown. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: arm as sore as dickens; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 2nd June 2022, the patient received the 2nd dose of Shingrix. In June 2022, less than a week after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.     Additional Information: GSK Receipt Date: 03-JUN-2022 Reporter's Comments:  The patient self-reported this case via interactive digital media. The patient said just got his/her Shingrix shot yesterday (day before reporting), insurance covers it 100 percent. The patient said it made arm as sore as the dickens for several days, but it beats getting shingles.
Sex: U
Vaccine: VARZOS
Symptoms: Dizziness, Fatigue, Pyrexia
Clinical narrative: minor fatiguue; fever; Dizzy; This case was reported by a other health professional and described the occurrence of dizziness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 22nd March 2022, the patient received the 1st dose of Shingrix. On 23rd March 2022, 1 days after receiving Shingrix, the patient experienced dizziness. On an unknown date, the patient experienced fatigue and fever. On an unknown date, the outcome of the dizziness, fatigue and fever were recovered/resolved.   It was unknown if the reporter considered the dizziness, fatigue and fever to be related to Shingrix.  GSK Receipt Date: 05-JUN-2022 Reporter's Comment: The patient got Shingrix and the following day was dizzy.  The patient had expected minor fatigue and fever which he/she did experience.  All symptoms were dissipated by the third day. The patient decided to not get the recommended Shingrix booster because the dizziness could be dangerous and also, because he/she could not find any evidence why the booster was necessary. Less than 3 months after vaccination, the patient had expected minor fatigue and fever which he/she did experience.  The reporter asked that, what made GlaxoSmithKline think that a single Shingrix was not adequate if you never did a study on a single dose. The reporter further asked that, why did the FDA (Food and Drug Administration) approve two doses when the manufacturer supplied no data on the efficacy of a single dose.
Sex: U
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: Had a rash reaction like almost I was having them; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Concurrent medical conditions included disability.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 3-Jun-2022 Reporter's comments: This case was reported by the patient via interactive digital media. The patient had dual insurances and was disabled, and the patient's shots were always covered. The patient got the shingles shot but had a rash reaction to it like almost like he or she was having them. Additional Supportive Information: The follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Bell's palsy
Clinical narrative: I had the shot developed Bells Palsy; This case was reported by a consumer via interactive digital media and described the occurrence of bell's palsy in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced bell's palsy (serious criteria GSK medically significant). On an unknown date, the outcome of the bell's palsy was unknown.   It was unknown if the reporter considered the bell's palsy to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 03-JUN-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had the shingles shot and developed Bell's Palsy. The patient also stated many others also experienced Bells palsy and asked to research it. The patient further stated, some women's face never went back to normal. Additional supportive information: follow up could not be possible, as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: have gotten both of the vaccinations, I still get the shingles/suspected vaccination failure; still get the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (experienced shingles before vaccination).   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 5-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient had both of the shingle vaccinations and  still get the shingles and they were worse now than they were before the shots. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles was not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: severe case of shingles after receiving the shingles vaccine/suspected vaccination failure; severe case of shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 5-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The case was reported by patient's son/ daughter. The reporter stated that the patient  broke out with a severe case of shingles after receiving the shingles vaccine. This jab was such bullshit. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got shingles from the vaccine (shingrex)/suspected vaccination failure; got shingles from the vaccine (shingrex); This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be related to Shingrix.     Additional Information: GSK receipt date: 5-June-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient actually got shingles from the vaccine (shingrex). It was very rare. The patient stated that if you get symptoms after don't ignore them. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles was not provided.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: suspected vaccination failure; Received the vaccine, both doses, in August and October 2019/ I had shingles on my face; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included immunosuppressive drugs. Concurrent medical conditions included lymphoproliferative disorder (had iatrogenic immunodeficiency-associated lymphoproliferative disorders (B-cell type) caused by immunosuppressive drugs).   In October 2019, the patient received the 2nd dose of Shingrix. In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, more than a year after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     Additional Information: GSK receipt date: 3-June-2022 Reporter's comment: This case was reported by a consumer via interactive digital media. The patient received the Shingrix vaccine, both doses, in August and October 2019. Recently, the patient had shingles on face. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles was not provided.